Healy, Brian C. http://orcid.org/0000-0001-5272-2425
Zurawski, Jonathan
Chitnis, Tanuja
Weiner, Howard L.
Glanz, Bonnie I.
Article History
Accepted: 3 November 2021
First Online: 16 November 2021
Declarations
:
: Brian Healy has received grant support from Analysis Group, Celgene (Bristol-Myers Squibb), Verily, Novartis, Merck Serono, and Genzyme. Jonathan Zurawski reports no disclosures relevant to the manuscript. Tanuja Chitnis has provided advisory board/consulting services to Biogen-Idec, Merck Serono, Novartis, Sanofi, Bayer, Celgene (Bristol-Myers Squibb), and Alexion and has received research support from Verily, Merck Serono, and Novartis. Howard Weiner has received grant support from National Institutes of Health, National Multiple Sclerosis Society, Verily, Google Life Sciences, EMD Serono, Biogen, Teva, and Novartis, has received grant support and provided consulting services to Sanofi and Genentech, has provided personal, consulting, and/or advising services to Tilos, Tiziana, IM Therapeutics, vTv Therapeutics, and MedDay. Bonnie Glanz has received research support from Merck Serono and Verily.
: This study was approved by the Mass General Brigham IRB.
: All subjects provided written informed consent.